Perrigo Company plc Operating Leases, Future Minimum Payments, Due in Three Years
Perrigo Company plc (PRGO) had Operating Leases, Future Minimum Payments, Due in Three Years of $24.90 million as of 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-02-27
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $24.90M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $24.30M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $24.10M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $31.70M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $24.90M 10-K · filed 2019-02-27 |
| 2017-12-31 | $24.30M 10-K · filed 2018-03-01 |
| 2016-12-31 | $24.10M 10-K · filed 2017-05-22 |
| 2015-12-31 | $31.70M 10-KT · filed 2016-02-25 |
| 2015-06-27 | $32.30M 10-K · filed 2015-08-13 |
| 2014-06-28 | $17.30M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |